Advanced in IgG4-Related Disease

Bruno G. Baldi

Sao Paulo, SP, BR 
Advanced in IgG4-Related Disease
Sao Paulo, SP, BR 
OverviewLocationsClinical Research

Overview

Bruno Baldi practices in Sao Paulo, Brazil. Mr. Baldi is rated as an Advanced expert by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Lymphangioleiomyomatosis, Hypersensitivity Pneumonitis, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

His clinical research consists of co-authoring 92 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of IgG4-Related Disease.

Gender
Male

Locations

Sao Paulo, SP, Brazil
Other Locations
Brasilia, DF, Brazil
Paulo, MA, Brazil
Ribeirao Preto, SP, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: August 12, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Clinical Profile Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma Followed at Hospital Das Clínicas, University of Sao Paulo Medical School
Clinical Profile Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma Followed at Hospital Das Clínicas, University of Sao Paulo Medical School
Enrollment Status: Completed
Publish Date: August 04, 2022
Randomized, Double-Blind Clinical Trial of Ruxolitinib in Patients With Acute Respiratory Disorder Syndrome Due to SARS-CoV-2 Infection
Randomized, Double-Blind Clinical Trial of Ruxolitinib in Patients With Acute Respiratory Disorder Syndrome Due to SARS-CoV-2 Infection
Enrollment Status: Terminated
Publish Date: April 08, 2021
Intervention Type: Other, Drug
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

92 Total Publications

Sirolimus Use During Pregnancy in Women with Lymphangioleiomyomatosis.
Sirolimus Use During Pregnancy in Women with Lymphangioleiomyomatosis.
Journal: Annals of the American Thoracic Society
Published: June 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Baldi's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 25 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile